Financial Statements · From SEC 10-K & 10-Q XBRL Filings
Aehr Test Systems Revenue & Financial Statements
Aehr Test Systems reported revenue of $59.0M for the fiscal year ended May 30, 2025, down 10.9% year over year, with net income of $(3.9M) and diluted EPS of $-0.13.
- Company
- Aehr Test Systems AEHR · NASDAQ
- Latest fiscal year
- FY ended May 30, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 5 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 16.6M | 50.8M | 65.0M | 66.2M | 59.0M |
| Cost of revenue | 10.6M | 27.2M | 32.2M | 33.7M | 35.0M |
| Gross profit | 6.0M | 23.7M | 32.7M | 32.5M | 23.9M |
| Operating income | (4.2M) | 7.8M | 13.4M | 10.1M | (5.7M) |
| Pretax income | (13.1M) | 9.4M | 14.5M | 12.4M | (4.4M) |
| Net income | (2.0M) | 9.4M | 14.6M | 33.2M | (3.9M) |
| Diluted EPS | -0.09 | 0.34 | 0.50 | 1.12 | -0.13 |
| EBITDA | (3.9M) | 8.1M | 13.8M | 10.8M | (4.7M) |
Quarterly
| USD | Q1 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 13.1M | — | 13.5M | 18.3M | 14.1M | 11.0M | 9.9M | 240K |
| Cost of revenue | 6.0M | — | 8.1M | 11.1M | 9.8M | 7.2M | 7.3M | 6.9M |
| Gross profit | 7.1M | — | 5.4M | 7.2M | 4.3M | 3.7M | 2.5M | 3.4M |
| Operating income | 159K | — | (1.5M) | (1.1M) | (3.2M) | (4.1M) | (4.6M) | (4.2M) |
| Pretax income | 814K | — | (1.2M) | (874K) | (3.0M) | (2.8M) | (4.4M) | (4.0M) |
| Net income | 660K | 660K | (1.0M) | (643K) | (2.9M) | (2.1M) | (3.2M) | (3.2M) |
| Diluted EPS | 0.02 | 0.02 | -0.03 | -0.02 | -0.10 | -0.07 | -0.11 | -0.10 |
| EBITDA | 359K | — | (1.3M) | (919K) | (2.8M) | (3.7M) | (4.2M) | (3.6M) |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total assets | 21.7M | 62.3M | 98.1M | 127.9M | 148.5M |
| Current assets | 19.2M | 60.0M | 89.0M | 97.8M | 88.8M |
| Cash & equivalents | 4.6M | 31.5M | 30.1M | 49.2M | 24.5M |
| Total liabilities | 10.2M | 11.3M | 22.5M | 16.3M | 25.6M |
| Current liabilities | 9.1M | 11.0M | 16.3M | 10.5M | 15.6M |
| Long-term debt | 0 | — | — | — | — |
| Total debt | 1.7M | 0 | — | — | — |
| Stockholders’ equity | 11.4M | 51.0M | 75.6M | 111.6M | 122.9M |
| Net debt | (2.9M) | (31.5M) | — | — | — |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | (2.7M) | 1.5M | 10.0M | 1.8M | (7.4M) |
| Investing cash flow | (227K) | (416K) | (18.7M) | 17.3M | (16.1M) |
| Financing cash flow | 2.0M | 25.8M | 7.3M | 139K | 625K |
| Capital expenditure | 227K | 416K | 1.4M | 749K | 5.0M |
| Free cash flow | (2.9M) | 1.1M | 8.6M | 1.0M | (12.4M) |
| Dividends paid | — | — | — | — | — |
| Stock-based compensation | 1.1M | 3.0M | 2.7M | 2.5M | 5.2M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every AEHR filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.